Dr James Nicholson - Publications

Frazier L, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Shaikh F, Pashankar F, Stoneham S, Krailo M, Nicholson JC. Revised Risk Classification for Pediatric Extracranial Germ Cell Tumors Based on 25 Years of Clinical Trial Data from the United Kingdom and United States. J Clin Oncol. 2015, Jan 10;33(2):195-201

01 Dec 2014

Murray MJ, Bartels U, Nishikawa R, Fangusaro J, Matsutani M, Nicholson JC. 'Consensus in the management of intracranial germ-cell tumours'. Lancet Oncol. 2015 Sep;16(9):e470-7.

01 Sep 2015

Calaminus G, Frappaz D, Kortmann R, Krefeld B, Saran F, Pietsch T, Vasiljevic A, Garre M, Ricardi U, Mann J, Göbel U, Alapetite C, Murray MJ, Nicholson JC. Outcome of patients with intracranial non-germinomatous germ cell tumors – lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol. 2017 Nov 29;19(12):1661-1672.

05 Jul 2017

Murray MJ, Bailey S, Heinemann K, Mann J, Göbel UK, Saran F, Hale JP, Calaminus G, Nicholson JC. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy. Int J Cancer 2017 Aug 1;141(3):621-635.

15 May 2017

Frazier L, Stoneham S, Rodriguez-Galindo C, Dang H; Xia C, Olson T, Murray MJ, Amatruda J, Arul GS, Shaikh F, Billmire D, Krailo M, Stark D, Brougham M, Nicholson JC, Hale JP. Comparison of Carboplatin vs. Cisplatin in the Treatment of Paediatric Malignant Germ Cell Tumours: A Report of the Malignant Germ Cell International Consortium. Eur J Cancer, 2018 Jul;98:30-37

01 Jul 2018

S Depani S, Stoneham S, Krailo M, Xia C, Nicholson J. Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in Children & Adolescents (GC3). Eur J Cancer. 2019 Sep;118:49-57

12 Jul 2019

Murray MJ, Ajithkumar T, Harris F, Williams R, Jalloh I, Cross J, Rhonge M, Ward D, Scarpini C, Nicholson JC+ and Coleman N+ (+ equal contrib). Clinical utility of circulating miR-371a-3p for management of patients with intracranial malignant GCTs. Neuro-oncology Adv, 2020 Apr 13, 2(1),1-10

01 Apr 2020

Calaminus G, Bison B, Conter C, Frappaz D, Peyrl A, Gerber N, Müller J-E, Ajithkumar TV, Mitra D, Cross J, Pietsch T, Smith C, Solem K, Devenney I, Garre M, Brisse H, Zimmermann M, Kortmann R, Alapetite C, Nicholson J. 24Gy whole ventricular radiotherapy alone is sufficient for disease control in localised Germinoma in CR after initial chemotherapy – early results of the SIOP CNS GCT II study. Neuro-Oncology vol 22 Supp 3, Dec 2020, p343-344

01 Dec 2020

Murray MJ, Ruffle A, Lowis S, Howell L, Shanmugavadivel D, Dommett R, Gamble A, Shenton G, Nicholson JC. A Delphi method to identify expert opinion to support children’s cancer referral guidelines. Arch Dis Child. Arch Dis Child. 2020 Mar;105(3):241-246.

01 Mar 2020

Murray MJ, Moleron R, Adamski J, English M, Burke GAA, Cross J, Ajithkumar T, Stoneham S, Nicholson JC. Vinblastine monotherapy induction prior to radiotherapy for patients with intracranial Germinoma during the COVID-19 pandemic. Pediatr Blood Cancer.2022 Jan;69(1):e29359. doi: 10.1002/pbc.29359. Epub 2021 Sep 14

01 Jan 2022